The global drug discovery outsourcing market is experiencing robust growth as pharmaceutical and biotechnology companies increasingly rely on external expertise to accelerate innovation and reduce operational costs. Valued at US$ 3.6 billion in 2022, the market is projected to surpass US$ 7.5 billion by 2031, expanding at a CAGR of 7.8% during the forecast period. This growth is driven by...